{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:44:55Z","timestamp":1789591495091,"version":"build-2803163510"},"reference-count":106,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Russian Ministry of Science and Higher Education","award":["075-15-2020-777"],"award-info":[{"award-number":["075-15-2020-777"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Effective therapeutics for Alzheimer\u2019s disease (AD) are in great demand worldwide. In our previous work, we responded to this need by synthesizing novel drug candidates consisting of 4-amino-2,3-polymethylenequinolines conjugated with butylated hydroxytoluene via fixed-length alkylimine or alkylamine linkers (spacers) and studying their bioactivities pertaining to AD treatment. Here, we report significant extensions of these studies, including the use of variable-length spacers and more detailed biological characterizations. Conjugates were potent inhibitors of acetylcholinesterase (AChE, the most active was 17d IC50 15.1 \u00b1 0.2 nM) and butyrylcholinesterase (BChE, the most active was 18d: IC50 5.96 \u00b1 0.58 nM), with weak inhibition of off-target carboxylesterase. Conjugates with alkylamine spacers were more effective cholinesterase inhibitors than alkylimine analogs. Optimal inhibition for AChE was exhibited by cyclohexaquinoline and for BChE by cycloheptaquinoline. Increasing spacer length elevated the potency against both cholinesterases. Structure\u2013activity relationships agreed with docking results. Mixed-type reversible AChE inhibition, dual docking to catalytic and peripheral anionic sites, and propidium iodide displacement suggested the potential of hybrids to block AChE-induced \u03b2-amyloid (A\u03b2) aggregation. Hybrids also exhibited the inhibition of A\u03b2 self-aggregation in the thioflavin test; those with a hexaquinoline ring and C8 spacer were the most active. Conjugates demonstrated high antioxidant activity in ABTS and FRAP assays as well as the inhibition of luminol chemiluminescence and lipid peroxidation in mouse brain homogenates. Quantum-chemical calculations explained antioxidant results. Computed ADMET profiles indicated favorable blood\u2013brain barrier permeability, suggesting the CNS activity potential. Thus, the conjugates could be considered promising multifunctional agents for the potential treatment of AD.<\/jats:p>","DOI":"10.3390\/molecules29020321","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T03:36:58Z","timestamp":1704771418000},"page":"321","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Combining Experimental and Computational Methods to Produce Conjugates of Anticholinesterase and Antioxidant Pharmacophores with Linker Chemistries Affecting Biological Activities Related to Treatment of Alzheimer\u2019s Disease"],"prefix":"10.3390","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8136-6906","authenticated-orcid":false,"given":"Galina F.","family":"Makhaeva","sequence":"first","affiliation":[{"name":"Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka 142432, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4990-5068","authenticated-orcid":false,"given":"Nadezhda V.","family":"Kovaleva","sequence":"additional","affiliation":[{"name":"Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka 142432, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Rudakova","sequence":"additional","affiliation":[{"name":"Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka 142432, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7171-8832","authenticated-orcid":false,"given":"Natalia P.","family":"Boltneva","sequence":"additional","affiliation":[{"name":"Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka 142432, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6922-020X","authenticated-orcid":false,"given":"Sofya V.","family":"Lushchekina","sequence":"additional","affiliation":[{"name":"Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka 142432, Russia"},{"name":"Emanuel Institute of Biochemical Physics Russian Academy of Sciences, Moscow 119334, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana Y.","family":"Astakhova","sequence":"additional","affiliation":[{"name":"Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka 142432, Russia"},{"name":"Emanuel Institute of Biochemical Physics Russian Academy of Sciences, Moscow 119334, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena N.","family":"Timokhina","sequence":"additional","affiliation":[{"name":"Emanuel Institute of Biochemical Physics Russian Academy of Sciences, Moscow 119334, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor V.","family":"Serkov","sequence":"additional","affiliation":[{"name":"Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka 142432, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3970-5767","authenticated-orcid":false,"given":"Alexey N.","family":"Proshin","sequence":"additional","affiliation":[{"name":"Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka 142432, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6929-0638","authenticated-orcid":false,"given":"Yuliya V.","family":"Soldatova","sequence":"additional","affiliation":[{"name":"Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka 142432, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4315-9180","authenticated-orcid":false,"given":"Darya A.","family":"Poletaeva","sequence":"additional","affiliation":[{"name":"Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka 142432, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4926-3859","authenticated-orcid":false,"given":"Irina I.","family":"Faingold","sequence":"additional","affiliation":[{"name":"Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka 142432, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriya A.","family":"Mumyatova","sequence":"additional","affiliation":[{"name":"Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka 142432, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2259-8184","authenticated-orcid":false,"given":"Alexey A.","family":"Terentiev","sequence":"additional","affiliation":[{"name":"Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka 142432, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2091-7022","authenticated-orcid":false,"given":"Eugene V.","family":"Radchenko","sequence":"additional","affiliation":[{"name":"Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka 142432, Russia"},{"name":"Department of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8792-8386","authenticated-orcid":false,"given":"Vladimir A.","family":"Palyulin","sequence":"additional","affiliation":[{"name":"Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka 142432, Russia"},{"name":"Department of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3637-818X","authenticated-orcid":false,"given":"Sergey O.","family":"Bachurin","sequence":"additional","affiliation":[{"name":"Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka 142432, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-5723","authenticated-orcid":false,"given":"Rudy J.","family":"Richardson","sequence":"additional","affiliation":[{"name":"Department of Environmental Health Sciences, University of Michigan, Ann Arbor, MI 48109, USA"},{"name":"Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA"},{"name":"Center of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA"},{"name":"Michigan Institute for Computational Discovery and Engineering, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","article-title":"Alzheimer\u2019s Disease: Epidemiology and Clinical Progression","volume":"11","author":"Byrnes","year":"2022","journal-title":"Neurol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association (2020). 2020 Alzheimer\u2019s disease facts and figures. Alzheimers Dement., 16, 391\u2013460.","DOI":"10.1002\/alz.12068"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.12688\/f1000research.14506.1","article-title":"Current understanding of Alzheimer\u2019s disease diagnosis and treatment","volume":"7","author":"Weller","year":"2018","journal-title":"F1000Res"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2174\/15680266113139990135","article-title":"The multifactorial nature of Alzheimer\u2019s disease for developing potential therapeutics","volume":"13","author":"Carreiras","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1021\/acs.jmedchem.1c00048","article-title":"Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer\u2019s Disease","volume":"64","author":"Rossi","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1039\/C9MD00337A","article-title":"Current and emerging therapeutic targets of alzheimer\u2019s disease for the design of multi-target directed ligands","volume":"10","author":"Blaikie","year":"2019","journal-title":"MedChemComm"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Blaszczyk, J.W. (2022). Pathogenesis of Dementia. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010543"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1567205054367838","article-title":"Cholinesterases: Roles in the Brain During Health and Disease","volume":"2","author":"Ballard","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.biopha.2018.06.147","article-title":"A molecular approach in drug development for Alzheimer\u2019s disease","volume":"106","author":"Kettle","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Moreta, M.P., Burgos-Alonso, N., Torrecilla, M., Marco-Contelles, J., and Bruzos-Cid\u00f3n, C. (2021). Efficacy of Acetylcholinesterase Inhibitors on Cognitive Function in Alzheimer\u2019s Disease. Review of Reviews. Biomedicines, 9.","DOI":"10.3390\/biomedicines9111689"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2125.1999.00026.x","article-title":"Acetylcholinesterase inhibitors in Alzheimer\u2019s disease","volume":"48","author":"McGleenon","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2147\/TCRM.S323387","article-title":"Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review","volume":"17","author":"Ruangritchankul","year":"2021","journal-title":"Ther. Clin. Risk. Manag."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/acs.chemrev.8b00138","article-title":"Development of multifunctional molecules as potential therapeutic candidates for Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis in the last decade","volume":"119","author":"Savelieff","year":"2019","journal-title":"Chem. Rev."},{"key":"ref_15","first-page":"535","article-title":"Oxidative stress in Alzheimer disease as a target for therapy","volume":"119","author":"Pohanka","year":"2018","journal-title":"Bratisl. Lek. Listy"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"102294","DOI":"10.1016\/j.ctim.2019.102294","article-title":"Oxidative stress in alzheimer\u2019s disease: A review on emergent natural polyphenolic therapeutics","volume":"49","author":"Cassidy","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1517\/13543784.11.10.1407","article-title":"Antioxidants as treatment for neurodegenerative disorders","volume":"11","author":"Moosmann","year":"2002","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Olufunmilayo, E.O., Gerke-Duncan, M.B., and Holsinger, R.M.D. (2023). Oxidative Stress and Antioxidants in Neurodegenerative Disorders. Antioxidants, 12.","DOI":"10.3390\/antiox12020517"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/joim.12192","article-title":"Pathways to Alzheimer\u2019s disease","volume":"275","author":"Hardy","year":"2014","journal-title":"J. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/aps.2011.14","article-title":"Small molecule inhibitors of amyloid beta peptide aggregation as a potential therapeutic strategy for Alzheimer\u2019s disease","volume":"32","author":"Nie","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"101496","DOI":"10.1016\/j.arr.2021.101496","article-title":"Past, present and future of therapeutic strategies against amyloid-beta peptides in Alzheimer\u2019s disease: A systematic review","volume":"72","author":"Jeremic","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"10447","DOI":"10.1021\/bi0101392","article-title":"A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation","volume":"40","author":"Canales","year":"2001","journal-title":"Biochemistry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-2952(02)01514-9","article-title":"\u03b2-Amyloid aggregation induced by human acetylcholinesterase: Inhibition studies","volume":"65","author":"Bartolini","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1742-4658.2007.06238.x","article-title":"Amyloid-cholinesterase interactions. Implications for Alzheimer\u2019s disease","volume":"275","author":"Inestrosa","year":"2008","journal-title":"FEBS J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12668-016-0375-x","article-title":"Role of Acetylcholinesterase in \u03b2-Amyloid Aggregation Studied by Accelerated Molecular Dynamics","volume":"7","author":"Lushchekina","year":"2017","journal-title":"BioNanoScience"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1021\/jm0503289","article-title":"Design, Synthesis, and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors:\u2009 New Disease-Modifying Agents for Alzheimer\u2019s Disease","volume":"48","author":"Rubio","year":"2005","journal-title":"J. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cbi.2010.02.013","article-title":"Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates","volume":"187","author":"Camps","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuropharm.2019.05.025","article-title":"New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer\u2019s disease","volume":"155","author":"Zueva","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/mp.2013.19","article-title":"APOE and BCHE as modulators of cerebral amyloid deposition: A florbetapir PET genome-wide association study","volume":"19","author":"Ramanan","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2174\/1567205013666160404120542","article-title":"Butyrylcholinesterase as a diagnostic and therapeutic target for Alzheimer\u2019s disease","volume":"13","author":"Darvesh","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2174\/1570159X19666201218103434","article-title":"Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors","volume":"19","author":"Przybylowska","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2174\/1568026605666160927152728","article-title":"Multitarget tacrine hybrids with neuroprotective properties to confront Alzheimer\u2019s disease","volume":"17","author":"Spilovska","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejmech.2016.10.060","article-title":"A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer\u2019s disease","volume":"128","author":"Sameem","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2174\/1570159X16666180412091908","article-title":"Therapeutic Potential of Multifunctional Tacrine Analogues","volume":"17","author":"Przybylowska","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Bubley, A., Erofeev, A., Gorelkin, P., Beloglazkina, E., Majouga, A., and Krasnovskaya, O. (2023). Tacrine-Based Hybrids: Past, Present, and Future. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021717"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Makhaeva, G.F., Kovaleva, N.V., Boltneva, N.P., Lushchekina, S.V., Astakhova, T.Y., Rudakova, E.V., Proshin, A.N., Serkov, I.V., Radchenko, E.V., and Palyulin, V.A. (2020). New Hybrids of 4-Amino-2,3-polymethylene-quinoline and p-Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer\u2019s Disease Treatment. Molecules, 25.","DOI":"10.3390\/molecules25173915"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Makhaeva, G.F., Kovaleva, N.V., Rudakova, E.V., Boltneva, N.P., Grishchenko, M.V., Lushchekina, S.V., Astakhova, T.Y., Serebryakova, O.G., Timokhina, E.N., and Zhilina, E.F. (2023). Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer\u2019s Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032285"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Pi, R., Mao, X., Chao, X., Cheng, Z., Liu, M., Duan, X., Ye, M., Chen, X., Mei, Z., and Liu, P. (2012). Tacrine-6-ferulic acid, a novel multifunctional dimer, inhibits amyloid-beta-mediated Alzheimer\u2019s disease-associated pathogenesis in vitro and in vivo. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031921"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"8985","DOI":"10.1021\/acs.jmedchem.5b01325","article-title":"Tacrine-Trolox Hybrids: A Novel Class of Centrally Active, Nonhepatotoxic Multi-Target-Directed Ligands Exerting Anticholinesterase and Antioxidant Activities with Low In Vivo Toxicity","volume":"58","author":"Nepovimova","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1039\/C9MD00048H","article-title":"Synthesis of novel vanillin derivatives: Novel multi-targeted scaffold ligands against Alzheimer\u2019s disease","volume":"10","author":"Scipioni","year":"2019","journal-title":"MedChemComm"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"111550","DOI":"10.1016\/j.ejmech.2019.07.053","article-title":"Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer\u2019s disease: Selective subnanomolar BuChE inhibitors","volume":"181","author":"Hicke","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Makhaeva, G.F., Kovaleva, N.V., Rudakova, E.V., Boltneva, N.P., Lushchekina, S.V., Faingold, I.I., Poletaeva, D.A., Soldatova, Y.V., Kotelnikova, R.A., and Serkov, I.V. (2020). New Multifunctional Agents Based on Conjugates of 4-Amino-2,3-polymethylenequinoline and Butylated Hydroxytoluene for Alzheimer\u2019s Disease Treatment. Molecules, 25.","DOI":"10.3390\/molecules25245891"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0968-0896(98)00213-2","article-title":"Evaluation of short-tether bis-THA AChE inhibitors. A further test of the dual binding site hypothesis","volume":"7","author":"Carlier","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.cbi.2016.05.002","article-title":"Esterase profiles of organophosphorus compounds in vitro predict their behavior in vivo","volume":"259","author":"Makhaeva","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s11172-019-2507-2","article-title":"Cholinesterase and carboxylesterase inhibitors as pharmacological agents","volume":"68","author":"Makhaeva","year":"2019","journal-title":"Russ. Chem. Bull."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Makhaeva, G.F., Kovaleva, N.V., Boltneva, N.P., Lushchekina, S.V., Rudakova, E.V., Stupina, T.S., Terentiev, A.A., Serkov, I.V., Proshin, A.N., and Radchenko, E.V. (2020). Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer\u2019s disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation. Bioorg. Chem., 94.","DOI":"10.1016\/j.bioorg.2019.103387"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1007\/s11172-022-3668-y","article-title":"Synthesis and study of the biological activity of thiourea-containing amiridine derivatives as potential multi-target drugs for the treatment of Alzheimer\u2019s disease","volume":"71","author":"Makhaeva","year":"2022","journal-title":"Russ. Chem. Bull."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Jokar, S., Erfani, M., Bavi, O., Khazaei, S., Sharifzadeh, M., Hajiramezanali, M., Beiki, D., and Shamloo, A. (2020). Design of peptide-based inhibitor agent against amyloid-beta aggregation: Molecular docking, synthesis and in vitro evaluation. Bioorg. Chem., 102.","DOI":"10.1016\/j.bioorg.2020.104050"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jff.2015.01.043","article-title":"Hurdles and pitfalls in measuring antioxidant efficacy: A critical evaluation of ABTS, DPPH, and ORAC assays","volume":"14","author":"Schaich","year":"2015","journal-title":"J. Funct. Foods"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1021\/jf4010725","article-title":"Effects of molecular structure on kinetics and dynamics of the trolox equivalent antioxidant capacity assay with ABTS(+*)","volume":"61","author":"Tian","year":"2013","journal-title":"J. Agric. Food. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/13813459508996132","article-title":"Enhanced luminescence study of liver homogenate response to oxidative stress","volume":"103","author":"Venditti","year":"1995","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Baj, A., Cedrowski, J., Olchowik-Grabarek, E., Ratkiewicz, A., and Witkowski, S. (2019). Synthesis, DFT Calculations, and In Vitro Antioxidant Study on Novel Carba-Analogs of Vitamin E. Antioxidants, 8.","DOI":"10.3390\/antiox8120589"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.foodchem.2013.11.064","article-title":"Density functional theory study of the structure-antioxidant activity of polyphenolic deoxybenzoins","volume":"151","author":"Xue","year":"2014","journal-title":"Food Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"100515","DOI":"10.1016\/j.rechem.2022.100515","article-title":"Theoretical investigations on the antioxidant potential of 2,4,5-trihydroxybutyrophenone in different solvents: A DFT approach","volume":"4","author":"Hossen","year":"2022","journal-title":"Results Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.comptc.2015.09.007","article-title":"Revisiting the solvation enthalpies and free energies of the proton and electron in various solvents","volume":"1077","year":"2016","journal-title":"Comput. Theor. Chem."},{"key":"ref_58","first-page":"41","article-title":"Luminol-amplified chemiluminescence detects mainly superoxide anion produced by human neutrophils","volume":"7","year":"2017","journal-title":"Am. J. Blood Res."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Villaverde, A., Netherton, J., and Baker, M.A. (2019). From Past to Present: The Link Between Reactive Oxygen Species in Sperm and Male Infertility. Antioxidants, 8.","DOI":"10.3390\/antiox8120616"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.bbabio.2008.05.010","article-title":"Sites of generation of reactive oxygen species in homogenates of brain tissue determined with the use of respiratory substrates and inhibitors","volume":"1777","author":"Kudin","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_61","first-page":"75","article-title":"Superoxide Anion Radical, A Multipotent Reagent: A Review","volume":"7","author":"Raghuvanshi","year":"2020","journal-title":"Nat. Volatiles Essent. Oils"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1039\/B917636E","article-title":"Carotenoids can act as antioxidants by oxidizing the superoxide radical anion","volume":"12","author":"Galano","year":"2010","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.17221\/447\/2010-CJFS","article-title":"Antioxidant activity coefficient, mechanism, and kinetics of different derivatives of flavones and flavanones towards superoxide radical","volume":"30","author":"Ahmed","year":"2012","journal-title":"Czech J. Food Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1039\/D1TB00720C","article-title":"Superoxide dismutase nanozymes: An emerging star for anti-oxidation","volume":"9","author":"Zhao","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1468678319886129","article-title":"Oxidation reaction mechanism and kinetics between OH radicals and alkyl-substituted aliphatic thiols: H-abstraction pathways","volume":"45","author":"Tahan","year":"2020","journal-title":"Prog. React. Kinet. Mech."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00894-012-1601-2","article-title":"Modeling the activity of glutathione as a hydroxyl radical scavenger considering its neutral non-zwitterionic form","volume":"19","author":"Yadav","year":"2013","journal-title":"J. Mol. Model."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1021\/ja903856t","article-title":"How solvent modulates hydroxyl radical reactivity in hydrogen atom abstractions","volume":"132","author":"Mitroka","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Valgimigli, L. (2023). Lipid Peroxidation and Antioxidant Protection. Biomolecules, 13.","DOI":"10.3390\/biom13091291"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/s12161-020-01934-w","article-title":"Miniaturized Methodologies for Determining the Total Phenol and Flavonoid Concentrations and the Antioxidant Activity","volume":"14","author":"Cacique","year":"2021","journal-title":"Food Anal. Methods"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1021\/ja069149m","article-title":"Continuum of outer- and inner-sphere mechanisms for organic electron transfer. Steric modulation of the precursor complex in paramagnetic (ion-radical) self-exchanges","volume":"129","author":"Rosokha","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s41467-019-09392-7","article-title":"Efficient electron transfer across hydrogen bond interfaces by proton-coupled and -uncoupled pathways","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1016\/j.bmc.2017.09.028","article-title":"9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer\u2019s disease treatment","volume":"25","author":"Makhaeva","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1021\/bi00680a029","article-title":"Interaction of fluorescence probes with acetylcholinesterase. Site and specificity of propidium binding","volume":"14","author":"Taylor","year":"1975","journal-title":"Biochemistry"},{"key":"ref_74","first-page":"703","article-title":"Propidium\u2014A fluorescence probe for a peripheral anionic site on acetylcholinesterase","volume":"10","author":"Taylor","year":"1974","journal-title":"Mol. Pharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","article-title":"Quantification of beta-sheet amyloid fibril structures with thioflavin T","volume":"309","author":"LeVine","year":"1999","journal-title":"Methods Enzymol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0891-5849(98)00315-3","article-title":"Antioxidant activity applying an improved ABTS radical cation decolorization assay","volume":"26","author":"Re","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Makhaeva, G.F., Elkina, N.A., Shchegolkov, E.V., Boltneva, N.P., Lushchekina, S.V., Serebryakova, O.G., Rudakova, E.V., Kovaleva, N.V., Radchenko, E.V., and Palyulin, V.A. (2019). Synthesis, molecular docking, and biological evaluation of 3-oxo-2-tolylhydrazinylidene-4,4,4-trifluorobutanoates bearing higher and natural alcohol moieties as new selective carboxylesterase inhibitors. Bioorg. Chem., 91.","DOI":"10.1016\/j.bioorg.2019.103097"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: The FRAP assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal. Biochem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0076-6879(99)99005-5","article-title":"Ferric reducing\/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration","volume":"299","author":"Benzie","year":"1999","journal-title":"Methods Enzymol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Walker, J.M. (2002). The Protein Protocols Handbook, Humana Press. Springer Protocols Handbooks.","DOI":"10.1385\/1592591698"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1021\/acs.jcim.1c00075","article-title":"MolGpka: A Web Server for Small Molecule pKa Prediction Using a Graph-Convolutional Neural Network","volume":"61","author":"Pan","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/jcc.540141112","article-title":"General atomic and molecular electronic structure system","volume":"14","author":"Schmidt","year":"1993","journal-title":"J. Comp. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0065-3276(08)60339-1","article-title":"On the nonorthogonality problem","volume":"Volume 5","year":"1970","journal-title":"Advances in Quantum Chemistry"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1046\/j.1432-1033.2002.03271.x","article-title":"Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain","volume":"269","author":"Crescenzi","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comp. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comp. Chem."},{"key":"ref_89","unstructured":"Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Scalmani, G., Barone, V., Petersson, G.A., and Nakatsuji, H. (2016). Gaussian 16 Revision C. 01. 2016, Gaussian Inc."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s11172-005-0329-x","article-title":"PRIRODA-04: A quantum-chemical program suite. New possibilities in the study of molecular systems with the application of parallel computing","volume":"54","author":"Laikov","year":"2005","journal-title":"Russ. Chem. Bull."},{"key":"ref_91","unstructured":"Laikov, D.N. (2020). PRIRODA. Electronic Structure Code, Moscow State University. Version 19."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1063\/1.478522","article-title":"Toward reliable density functional methods without adjustable parameters: The PBE0 model","volume":"110","author":"Adamo","year":"1999","journal-title":"J. Chem. Phys."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1063\/1.467146","article-title":"Fully optimized contracted Gaussian basis sets of triple zeta valence quality for atoms Li to Kr","volume":"100","author":"Huber","year":"1994","journal-title":"J. Chem. Phys."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density-functional thermochemistry. III. The role of exact exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J. Chem. Phys."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"11623","DOI":"10.1021\/j100096a001","article-title":"Ab Initio Calculation of Vibrational Absorption and Circular Dichroism Spectra Using Density Functional Force Fields","volume":"98","author":"Stephens","year":"2002","journal-title":"J. Phys. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jcc.1058","article-title":"6-31G* basis set for third-row atoms","volume":"22","author":"Rassolov","year":"2001","journal-title":"J. Comp. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"154104","DOI":"10.1063\/1.3382344","article-title":"A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu","volume":"132","author":"Grimme","year":"2010","journal-title":"J. Chem. Phys."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1021\/jp810292n","article-title":"Universal solvation model based on solute electron density and on a continuum model of the solvent defined by the bulk dielectric constant and atomic surface tensions","volume":"113","author":"Marenich","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10822-011-9440-2","article-title":"Online chemical modeling environment (OCHEM): Web platform for data storage, model development and publishing of chemical information","volume":"25","author":"Sushko","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11172-016-1340-0","article-title":"Prediction of human intestinal absorption of drug compounds","volume":"65","author":"Radchenko","year":"2016","journal-title":"Russ. Chem. Bull."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1134\/S1607672916050173","article-title":"Prediction of blood-brain barrier permeability of organic compounds","volume":"470","author":"Dyabina","year":"2016","journal-title":"Dokl. Biochem. Biophys."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Radchenko, E.V., Dyabina, A.S., and Palyulin, V.A. (2020). Towards Deep Neural Network Models for the Prediction of the Blood-Brain Barrier Permeability for Diverse Organic Compounds. Molecules, 25.","DOI":"10.3390\/molecules25245901"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1134\/S1607672917020107","article-title":"Computer-aided estimation of the hERG-mediated cardiotoxicity risk of potential drug components","volume":"473","author":"Radchenko","year":"2017","journal-title":"Dokl. Biochem. Biophys."},{"key":"ref_104","unstructured":"(2022, June 15). ADMET Prediction Service. Available online: http:\/\/qsar.chem.msu.ru\/admet\/."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nchem.1243","article-title":"Quantifying the chemical beauty of drugs","volume":"4","author":"Bickerton","year":"2012","journal-title":"Nat. Chem."},{"key":"ref_106","unstructured":"(2022, June 15). RDKit: Open-Source Cheminformatics Software. Available online: http:\/\/www.rdkit.org."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/2\/321\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:42:42Z","timestamp":1760103762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/2\/321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":106,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["molecules29020321"],"URL":"https:\/\/doi.org\/10.3390\/molecules29020321","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]}}}